Cerebral Cavernous Malformation 2 (CCM2) Peptide
-
- Target See all CCM2 products
- CCM2 (Cerebral Cavernous Malformation 2 (CCM2))
- Origin
- Human, Cow, Dog, Mouse, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- KGEKSRDKKA HEK
- Characteristics
- The peptide was used in the production of ABIN369275 - Goat Anti-CCM2 Antibody. It is currently untested in blocking applications.
-
-
- Application Notes
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- CCM2 (Cerebral Cavernous Malformation 2 (CCM2))
- Synonyms
- C7orf22 Peptide, OSM Peptide, malcavernin Peptide, CCM2 Peptide, BC029157 Peptide, TUF2 Peptide, vtn Peptide, zgc:110233 Peptide, CCM2 scaffolding protein Peptide, cerebral cavernous malformation 2 Peptide, malcavernin Peptide, CCM2 Peptide, Ccm2 Peptide, LOC100304744 Peptide, ccm2 Peptide
-